title: Values and limits of combined use of 4 tumor markers (CEA, TPA, NSE and SCC) in un-treated patients with lung cancer.
authors.affiliation: Clinic of Respiratory Disease, University of Parma.
authors.forename: A
authors.initials: A
authors.lastname: Cuomo
authors.forename: R
authors.initials: R
authors.lastname: Capra
authors.forename: S
authors.initials: S
authors.lastname: Greco
authors.forename: G C
authors.initials: GC
authors.lastname: Cacciani
authors.forename: F
authors.initials: F
authors.lastname: Greco
authors.forename: D
authors.initials: D
authors.lastname: Franchini
authors.forename: P
authors.initials: P
authors.lastname: Bonelli
authors.forename: G
authors.initials: G
authors.lastname: Gavaruzzi
authors.forename: G
authors.initials: G
authors.lastname: Ugolotti
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen / Q000097:blood*; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis; D018288:Carcinoma, Small Cell / Q000175:diagnosis; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood*; D010751:Phosphopyruvate Hydratase / Q000097:blood*; D011863:Radioimmunoassay; D012680:Sensitivity and Specificity; D019396:Tissue Polypeptide Antigen
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen; D010751:Phosphopyruvate Hydratase